The two PAI proteins bestow different effects on cancer: cancers with high PAI-1 expression have been consistently demonstrated to have poorer clinical outcomes, whereas the effect of elevated PAI-2 expression levels are less well defined and the impact on clinical outcomes less pronounced [11,47]. Here, SERPINB2 is linked to cancer.